Glucosuria and albuminuria in diabetic nephropathy: a consideration at nanolevel

References 

1. Conti AA. Diabetic nephropathy. A historical, clinical and diagnostic framework. Minerva Medica. 2002;93:347–355
   • MEDLINE
2. Diem K, Lentner C. Scientific table. 7th ed.. Basle: CIBAGEIGY; 1971;
3. Inada A, Nagai K, Arai H, Miyazaki J, Nomura K, Kanamori H, et al. Establishment of a diabetic mouse model with progressive diabetic nephropathy. American Journal Pathology. 2005;167:327–336
4. Kawanishi K, Ishida T, Kajikawa T, Tada S. Clinical laboratory tests in diabetes mellitus. Rinsho Byori. 1994;42:779–785
   • MEDLINE
5. Life enhancement. Available at http://www.life-enhancement.com.
6. Mathieson PW. The cellular basis of albuminuria. Clinical Science (London). 2004;107:533–538
7. Ratner RE. Glycemic control in the prevention of diabetic complications. Clinical Cornerstone. 2001;4:24–37
   • MEDLINE
   • CrossRef
8. Sanchez-Lozada LG, Tapia E, Johnson RJ, Rodriguez-Iturbe B, Herrera-Acosta J. Glomerular hemodynamic changes associated with arteriolar lesions and tubulointerstitial inflammation. Kidney International Supplement. 2003;86:S9–S14
9. Wardle EN. How does hyperglycaemia predispose to diabetic nephropathy?. QJM. 1996;89:943–951
   • MEDLINE
   • CrossRef
10. Wen SF, Boynar JW, Stoll RW. Mechanism of glycosuria during volume expansion superimposed on subthreshold glucose loading. Journal of Laboratory and Clinical Medicine. 1983;101:708–716
11. Wiwanitkit V. Glomerular pore size corresponding to albumin molecular size, an explanation for underlying structural pathology leading to albuminuria at nanolevel. Renal Failure [in press].